Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bo Ursing is active.

Publication


Featured researches published by Bo Ursing.


Scandinavian Journal of Infectious Diseases | 1992

Septicemia in Granulocytopenic Patients: A Shift in Bacterial Etiology

P. J. Hugo Johansson; Erland Sternby; Bo Ursing

35 episodes of septicemia in 33 patients occurred among 269 consecutive patients with granulocytopenia (granulocyte cell count less than or equal to 0.5 x 10(9)/l) during the 7-year period 1982-1988. 59% of isolated bacteria were Gram-positive (Staphylococcus aureus, Staph. epidermidis, Streptococcus species and Pneumococcus) and 41% Gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter, Acinetobacter and Citrobacter). Compared to the 7-year period 1975-1981, there was a decrease in the relative number of patients with Gram-negative septicemia. Thus, a shift from a predominating Gram-negative etiology in the 1975-1981 period to a predominating Gram-positive etiology in the 1982-1988 period was noted. In both periods the mortality rate was high in patients with Gram-negative septicemia, especially in patients with a Ps, aeruginosa infection.


Scandinavian Journal of Infectious Diseases | 1984

Infectious complications to granulocytopenia

P. J. Hugo Johansson; Bo Ursing

A consecutive series of patients with granulocytopenia was analysed with consideration of rate and spectrum of infectious complications. The records of 98 patients from 1975-81 were studied retrospectively. Fever was the most common symptom of infection. 78 patients had one or more infectious manifestations, and Staphylococcus aureus was the most common pathogen isolated. Septicemia occurred in 22 patients of which 17 were caused by gram-negative bacteria. Pseudomonas aeruginosa caused septicemia in 8 patients. The risk of septicemia increased with a decreasing cell count and with the degree and duration of fever. The mortality rate for the whole group was 24% and for the septicemic patients 41%.


The Lancet | 1976

CHROMOSOME ABERRATIONS AND METRONIDAZOLE

Felix Mitelman; Beryl Hartley-Asp; Bo Ursing


Scandinavian Journal of Infectious Diseases | 1974

The Occurrence of Acute Pancreatitis in Mycoplasma Pneumoniae Infection

Per-Anders Mårdh; Bo Ursing


The Lancet | 1980

NO CYTOGENETIC EFFECT OF METRONIDAZOLE

Felix Mitelman; Bodil Strömbeck; Bo Ursing


Scandinavian Journal of Infectious Diseases | 1980

Chronic meningitis in patients with dental infections.

Sven Åke Hedström; C. E. Nord; Bo Ursing


Acta Pathologica Microbiologica Scandinavica Section B Microbiology | 2009

Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn's disease, as indicated by micro-immunofluorescence antibody tests.

Per-Anders Mårdh; Bo Ursing; Eva Sandgren


Hereditas | 2008

Metronidazole exhibits no clastogenic activity in a double‐blind cross‐over study on Crohn's patients

Felix Mitelman; Bodil Strömbeck; Bo Ursing; Orjan Nordle; Beryl Hartley-Asp


Acta Medica Scandinavica | 2009

Coagulation and fibrinolysis in young female arteritis.

Sune Isacson; Inga Marie Nilsson; Bertel Berg; Tord Karlefors; Bo Ursing


Scandinavian Journal of Infectious Diseases | 1979

Treatment of anaerobic infections with metronidazole.

Bertil Christensson; Sven Årke Hedström; Bo Ursing

Collaboration


Dive into the Bo Ursing's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carl Erik Nord

Karolinska University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge